RegenMed Systems Information

RegenMed Systems has developed a revolutionary FDA-approved, rapid, minimally-invasive, and clinically-proven system for harvesting bone marrow from a single puncture under local anesthesia. Our Marrow Harvesting System (MHS) represents the first significant improvement in bone marrow harvesting in over 50 years. RegenMed's Marrow Harvest System is based on improved technology initially developed at Stanford University for the "Marrow Miner" over the past decade. Our single-stick marrow collection technology improves both the quality and consistency of marrow and stem cell harvesting, while simultaneously reducing blood contamination and patient discomfort. RegenMed Systems seeks to partner with other innovative regenerative medicine companies focused on cell processing, delivery of bone marrow-derived stem cells, and others who use marrow-derived cells where our MHS synergistically improves clinical results with better initial stem cell harvest. Bone marrow is a rich source of adult stem and progenitor cells. These have been playing an increasingly valuable role in a widening array of regenerative therapies, of which bone marrow harvest is the critical upstream component. RegenMed is poised to advance marrow derived therapies in the large markets of cardiovascular disease, orthopedics, and beyond, facilitating the growing wave of Regenerative Medicine.